The University of Maryland Greenebaum Cancer Center (UMGCC) is a premier cancer research and treatment center devoted to providing cutting-edge therapies and individualized care for cancer patients.
The Cigarette Restitution Fund Program enables UMGCC to invest in people, technology and facilities to generate research breakthroughs that will improve the diagnosis, treatment and survival of people faced with cancer in the years to come.
The University of Maryland Greenebaum Cancer Center is known for its:
At UMGCC, patients are the foundation and focus of what we do. In our clinics and in our labs, physicians and researchers are working together to offer new hope to cancer patients -- through better prevention, better detection, and better treatment for all types of cancer.